Trial ID 14059 | Maryland Oncology Hematology Trial ID 14059 – Maryland Oncology Hematology

Trial ID 14059

Trial Information - Phase I/II

Phase I/II trial of Ibrutinib plus Trastuzumab in HER2-amplified Metastatic Breast Cancer

Disease Specifics: (mHER2+)

Protocol ID: 14059

Sponsor: PHARMACYCLICS

Status: OPEN TO ENROLLMENT

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Breast

Investigator

O'Connor MD, Shannon

Status

OPEN TO ENROLLMENT

Sponsor

PHARMACYCLICS

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology